Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Sales | 0 | 0 | 0 | 0 | 130 |
| Operating Expenses | 102 | 78 | 76 | 96 | 161 |
| Operating Income | -102 | -78 | -76 | -96 | -31 |
| Other Income | 8 | 3 | 2 | 2 | -5 |
| Pre-tax Income | -95 | -75 | -74 | -95 | -36 |
| Net Income Continuous | -95 | -75 | -74 | -95 | -36 |
| Net Income | $-95 | $-75 | $-74 | $-95 | $-36 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EBITDA(a) | $-102 | $-78 | $-76 | $-96 | $-31 |